Abivax (ABVX) EBIT Margin (2024 - 2026)
Powered by 
Analysis
Abivax (ABVX) EBIT Margin (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.70 Bn | 1,138.29 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 647.50 Bn | 567.36 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.26 Bn | 477.37 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 368.38 Bn | 322.75 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 303.14 Bn | 267.13 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 268.24 Bn | 241.93 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 242.50 Bn | 197.90 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.79 Bn | 168.99 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 173.14 Bn | 119.78 Bn | 10.94 Bn | 28.37% |
| 10 | Abivax | 6.26 Bn | 3.90 Bn | - | -185.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -185.51% |
| Sep 30, 2025 | -83.72% |
| Jun 30, 2025 | -833.56% |
| Mar 31, 2025 | -2,190.26% |
| Dec 31, 2024 | -19,942.33% |
| Sep 30, 2024 | -479.96% |
| Jun 30, 2024 | -378.51% |
| Mar 31, 2024 | -660.62% |
API Access
Abivax EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ABVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ABVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();